Recent Quarter Total Invested
$50,000
Recent Quarter Institutional Ownership Percentage
0.05%
Total Invested of Last Quarter
$2.91 M
Ownership Percentage of Last Quarter
16.07%
Inhibikase Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HAMILTON LANE ADVISORS LLC | 08/08/2023 | 13,802 | $50,000 | -83.33% | 0.05% |
| WELLS FARGO & COMPANY/MN | 08/15/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BLAIR WILLIAM & CO/IL | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 08/03/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 07/27/2023 | 0 | $0 | -100.00% | 0.00% |
| REDMOND ASSET MANAGEMENT, LLC | 08/09/2023 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| KOSHINSKI ASSET MANAGEMENT, INC. | 07/28/2023 | 0 | $0 | -100.00% | 0.00% |
| CCG WEALTH MANAGEMENT, LLC | 07/14/2023 | 0 | $0 | -100.00% | 0.00% |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
Inhibikase Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IKT shares?
During the previous two years, 2 institutional investors and hedge funds held shares of Inhibikase Therapeutics, Inc.. The most heavily invested institutionals were:
ZEKE CAPITAL ADVISORS, LLC: 93,800
ACT CAPITAL MANAGEMENT, LLC: 937,500
-
What percentage of Inhibikase Therapeutics, Inc. stock is owned by institutional investors?
0.05% of Inhibikase Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IKT ?
Institutional investors have bought a total of 1.03 M shares in the last 24 months. This purchase volume represents approximately $2.37 M in transactions.